HIV Protease
Human immunodeficiency virus (HIV) protease, belonging to the aspartic proteinase family, is an enzyme encoded by the pol open reading frame (ORF) of HIV genome that catalyze the posttranslational processing of the HIV polyproteins to yield structural proteins of the viral core and enzymes. The chemical structure of a HIV protease molecule is a symmetrical homodimer in which the interface is formed primarily by a four-stranded antiparallel β-sheet. A conserved D25-T26-G27 triad has been identified in each HIV protease monomer, which is positioned in a loop forming part of the catalytic site. HIV protease has been found to cleave peptide bonds in the p55 gag and p160 gag-pol polyproteins as well as in various cellular proteins in vitro, including calmodulin, pro-interleukin 1β and NF-KB.
- B4950 Darunavir EthanolateSummary: nonpeptidic HIV protease inhibitor
- A8204 LopinavirSummary: HIV protease inhibitor,highly potent
- A8205 Atazanavir1 CitationSummary: HIV protease inhibitor,highly potent
- A4040 Atazanavir sulfate (BMS-232632-05)Summary: Protease inhibitor
- A8203 RitonavirSummary: HIV protease inhibitor
- A8206 Darunavir2 CitationSummary: HIV-1 protease inhibitor
- A8201 Amprenavir (agenerase)Summary: HIV-1 protease inhibitor
- A3253 BMS-6265292 CitationTarget: HIV-1 gp120Summary: HIV-1 attachment inhibitor
- A3421 Fosamprenavir Calcium SaltSummary: Prodrug of antiretroviral protease inhibitor amprenavir
- A3653 Nelfinavir MesylateSummary: HIV protease inhibitor,antiretroviral drug for HIV treatment